NCT02250872 - Effects of DPP4 Inhibitor on Cisplatin Induced Acute Kidney Injury | Biotech Hunter

Enrollment

182

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

February 28, 2018

Study Completion Date

June 30, 2018

Conditions

CancerCisplatin Adverse Reaction

Interventions

DRUG

Gemigliptin

Gemigliptin 100mg in 2 divided doses plus cisplatin

DRUG

Placebo

100mg in 2 divided doses plus cisplatin

DRUG

Cisplatin

All patients will receive intravenous cisplatin

Trial Locations (1)

RECRUITING

Seoul National University Bundang Hospital, Seongnam-si